Month: March 2022

CHRISTIANSTED, U.S. Virgin Islands, March 31, 2022 (GLOBE NEWSWIRE) — Altisource Asset Management Corporation (“AAMC” or the “Company”) (NYSE American: AAMC) today announced financial and operating results for the fourth quarter and full year of 2021. Recent Developments As previously announced on March 18, 2022, the Company has started operations of its Alternative Lending Group (ALG) with a capital commitment of $40 million.   As of March 31, 2022, the Company pipeline consists of the following:Description AmountLoans acquired $18,470,000Loans under evaluation 9,258,000Total 27,728,000Our Interim Chief Executive Officer, Thomas K. McCarthy, has had his engagement extended to May 31, 2022. Our new President and Chief Operating Officer, Jason Kopcak, will officially start his new position on or before May 15, 2022. Subsequent...

Arcimoto Earnings Arcimoto Announces Full Year 2021 Financial Results and Provides Corporate UpdateEUGENE, Ore., March 31, 2022 (GLOBE NEWSWIRE) — Arcimoto, Inc.® (NASDAQ: FUV), makers of rightsized, outrageously fun, ultra-efficient electric vehicles for moving people and stuff, today provided a corporate update and announced financial results for the fiscal year ended December 31, 2021. Arcimoto will host a stakeholder and analyst webinar at 2:00 p.m. PDT to discuss the company’s results and progress toward mass production. The webinar will include an analyst panel followed by an investor Q&A powered by Say. To view the webcast, use the link below: Arcimoto, Inc. Full Year 2021 Corporate UpdateDate: Thursday, March 31Time: 2:00 p.m. PDT (5:00 p.m. EDT)Webcast: https://us06web.zoom.us/webinar/register/WN_gC6U0PuRRCmHAz0lrN17Mg 2021...

FREMONT, CA, March 31, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in botanically based solutions that seeks to deliver high efficacy with low toxicity for improved health outcomes, today announced its financial and operating results for the fiscal year ended December 31, 2021. Full Year 2021 Financial ResultsAll comparisons are made on a year-over-year basis.Revenues. We generated $355,797 and $483,045 in revenues for the year ended December 31, 2021 and 2020, respectively. The decrease of $127,248, or approximately 26%, was primarily caused by the decrease in contract services due to the impact of the COVID-19 pandemic. Operating Expenses. Our operating expenses were $12,056,679 in the year ended December 31, 2021, as compared to $8,970,105 in the...

EXTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its financial and operational results for the fourth quarter and year ended December 31, 2021. “We are actively identifying and evaluating new development or commercial-stage assets for Idera’s portfolio while we continue to preserve cash,” stated Vincent Milano, Idera’s Chief Executive Officer. “In addition, we have asked JMP Securities, a Citizens Company, our current partner and advisor on business development activities, to expand their current scope of work beyond acquisition or in-licensing opportunities to include additional strategic alternatives for the Company.” Fourth Quarter Financial Results Our cash position as of December 31, 2021 was $32.5 million. Based on our current...

—Updated Data from Phase 1/2 study of IO102-IO103 in Combination with Nivolumab Showing High Response Rates in Metastatic Melanoma to be Presented at AACR in April– — Began Patient Recruitment for Global Phase 3 Combination Trial with Lead Asset IO102-IO103 and KEYTRUDA® (pembrolizumab) as First-Line Treatment in Advanced Melanoma– –Strong Cash Position with Runway to Support Multiple Data readouts into mid-2024– NEW YORK, March 31, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology platform, announced today financial results for the year ended December 31, 2021. “The past year has been a transformative period for IO Biotech, during which we made substantial progress...

– Revenues 31% Over Prior Period for the Year Ended December 31, 2021 CHARLOTTE, N.C., March 31, 2022 (GLOBE NEWSWIRE) — Manufactured Housing Properties Inc. (OTC: MHPC), which acquires, owns, and operates 43 manufactured housing communities containing approximately 2,037 developed sites, today announced operating results for the year ended December 31, 2021. Total revenues and EBITDA for the year ended December 31, 2021 were $8,362,277 and $2,856,497, respectively, compared to $6,380,515 and $3,927,206, respectively, for the year ended December 31, 2020. Raymond M. Gee, Chairman and CEO of Manufactured Housing Properties Inc. commented, “We had a strong year in growing our total revenue, which reflects the commitment and dedication of our team and our core values in providing affordable housing to our customers while maximizing...

Record-Breaking Full Year 2021 Net Revenue of $376 million, up 51% from 2020Record-Breaking Fourth Quarter Net Revenue of $97 million, up 78% from Fourth Quarter 2020 Full Year 2022 Net Revenue Outlook of $480-$490 million,Up 28%-30% from 2021 CHICO, Calif., March 31, 2022 (GLOBE NEWSWIRE) — Lulu’s Fashion Lounge Holdings, Inc. (“Lulus”) (Nasdaq: LVLU) today reported financial results for the fourth quarter and full year ended January 2, 2022. David McCreight, CEO of Lulus, said: “Our excellent fourth quarter results concluded a very exciting 2021 in which we completed our initial public offering and fully paid off our term loan, providing us a very strong balance sheet and greater flexibility to invest in our business going forward. Thanks to the tremendous work of the LuCrew, we had a record-breaking fourth quarter for certain...

– FY 2021 Net Revenue up 19% to $49.6 Million – – Q4 2021 Net Revenue up 20% to $12.8 Million – – Reed’s Reiterates 2022 Net Sales Outlook of $59-$62 Million with 30% Gross Margin – NORWALK, Conn., March 31, 2022 (GLOBE NEWSWIRE) — Reed’s, Inc. (NASDAQ: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, all-natural ginger beverages, is providing financial results for the three months and full year ended December 31, 2021. FY 2021 Financial Highlights (vs. FY 2020):Net revenue increased 19% to $49.6 million. Gross profit increased 7% to $13.6 million, with gross margin of 27.4% compared to 30.7%. Operating loss was $(15.9) million compared to $(8.6) million. Modified EBITDA was $(13.5) million compared to $(6.8) million.Q4 2021 Financial Highlights (vs....